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Abstract: Integrins are a family of cell surface receptors which mediate cell–matrix and 
cell–cell adhesions. Among other functions they provide an important mechanical link between 
the cells external and intracellular environments while the adhesions that they form also have 
critical roles in cellular signal-transduction. Cell–matrix contacts occur at zones in the cell 
surface where adhesion receptors cluster and when activated the receptors bind to ligands in 
the extracellular matrix. The extracellular matrix surrounds the cells of tissues and forms the 
structural support of tissue which is particularly important in connective tissues. Cells attach to 
the extracellular matrix through specific cell-surface receptors and molecules including integrins 
and transmembrane proteoglycans. Integrins work alongside other proteins such as cadherins, 
immunoglobulin superfamily cell adhesion molecules, selectins, and syndecans to mediate 
cell–cell and cell–matrix interactions and communication. Activation of adhesion receptors 
triggers the formation of matrix contacts in which bound matrix components, adhesion receptors, 
and associated intracellular cytoskeletal and signaling molecules form large functional, localized 
multiprotein complexes. Cell–matrix contacts are important in a variety of different cell and 
tissue properties including embryonic development, inflammatory responses, wound healing, 
and adult tissue homeostasis. This review summarizes the roles and functions of integrins and 
extracellular matrix proteins in mechanotransduction.
Keywords: ligand binding, α subunit, β subunit, focal adhesion, cell differentiation, mechanical 
loading, cell–matrix interaction
An introduction to integrins and the extracellular  
matrix (ECM)
Integrins are a family of αβ heterodimeric receptors which act as cell adhesion 
molecules connecting the ECM to the actin cytoskeleton. The actin cytoskeleton is 
involved in the regulation of cell motility, cell polarity, cell growth, and cell survival.1 
The integrin family consists of around 25 members which are composed of differing 
combinations of α and β subunits.2 The combination of αβ subunits determines binding 
specificity and signaling properties.3 In mammals around 19 α and eight β subunits 
have been characterized. Variants of some of the subunits exist which are formed 
from differential splicing (eg, four variants of the β1 subunit exist).4 Some integrin 
subunits are ubiquitously expressed, while other subunits are expressed in a tissue- or 
stage-restricted manner.5
Both α and β integrin subunits contain two separate tails, which penetrate the 
plasma membrane and possess small cytoplasmic domains which facilitate the signal-
ing functions of the receptor. There is some evidence that the β subunit is the principal 
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site for binding of cytoskeletal and signaling molecules, 
whereas the α subunit has a regulatory role.6 The integrin 
tails link the ECM to the actin cytoskeleton within the cell 
and with cytoplasmic proteins, such as talin, tensin, and 
filamin.7 The extracellular domains of integrin receptors bind 
the ECM ligands. Integrins can also associate laterally in the 
plasma membrane with other cell surface proteins, including 
tetraspanins, growth factor receptors, matricellular proteins, 
and matrix protease receptors.8
The ECM is a complex mixture of matrix molecules, including 
glycoproteins, collagens, laminins, glycosaminoglycans, 
proteoglycans, and nonmatrix proteins, including growth 
factors. These can be categorized as insoluble molecules 
within the ECM, soluble molecules, and/or matrix-associated 
biochemicals, such as systemic hormones or growth factors 
and cytokines that act locally.
The ECM contains many types of insoluble molecules 
which form a meshwork of structural proteins to which 
adhesive proteins, proteoglycans, and glycosaminoglycans 
are associated.9 This provides rigidity and support for the tis-
sue. Common insoluble structural matrix molecules include 
members of the collagen family. There are many types of 
collagen present in the ECM of tissues, including type I, 
III, IV, V, and the glycosaminoglycan-containing type XI.10 
Elastin is another common structural protein found in the 
ECM.11 The glycoprotein families, including proteoglycans 
and tenascins,12,13 can be present in the ECM as free soluble 
molecules or bound to substrates; the presentation of these 
molecules in the tissue as soluble or bound can result in dif-
fering cellular responses upon ligand binding.
ECM proteins are involved in various biological functions 
through their ability to bind multiple interacting partners such 
as other ECM proteins, growth factors, signal receptors, and 
other adhesion molecules. ECM proteins are secreted from cells 
and then integrate themselves into the matrix through binding 
via specific protein domains to form multiprotein interactions 
which regulate the structure and function of the tissue.14
Binding of integrins to the ECM
Some integrins show a high specificity for ligand binding, 
whereas most are more promiscuous and bind several 
different types of ligands. Most integrins recognize several 
ECM proteins, and several matrix proteins such as fibronec-
tin and collagens bind to several different integrins.15 There 
are four collagen receptor integrins (α1β1, α2β1, α10β1, 
and α11β1)16 and around ten different fibronectin receptor 
integrin receptors.17 Integrin receptors and their ligands are 
summarized in Table 1.18 The composition and proportion of 
molecules in the ECM can be tissue specific; collagen II is 
present only in hyaline cartilage. This diverse tissue specific 
expression of ECM results in different expression profiles of 
integrin receptors within the cellular membranes of tissues.
The integrin receptor formed from the binding of α and β 
subunits is shaped like a globular head supported by two 
rod-like legs (Figure 1). Most of the contact between the two 
subunits occurs in the head region, with the intracellular tails 
of the subunits forming the legs of the receptor.6 Integrin rec-
ognition of ligands is not constitutive but is regulated by altera-
tion of integrin affinity for ligand binding. For integrin binding 
to ligands to occur the integrin must be primed and activated, 
both of which involve conformational changes to the recep-
tor.2 The integrins are composed of well-defined domains19 
used for protein–protein  interactions. The α-I domains of α 
integrin subunits comprise the ligand binding sites. X-ray 
crystallography has identified an α-I domain within the β 
subunit and a β propeller domain within the α subunit which 
Table 1 Integrin receptors and their ligands; adapted from 
Barczyk et al18
Integrins Ligands
α1β1 Collagen (I, Iv, IX), laminin
α2β1 Collagen (I, Iv, IX), laminin
α3β1 Laminin
α4β1 Fibronectin, vCAM-1
α5β1 Fibronectin
α6β1 Laminin
α7β1 Laminin
α8β1 Fibronectin, vitronectin, nephronectin
α9β1 Tenancin C, vEGF-C vEGF-D
α10β1 Collagen (II, Iv, vI, IX)
α11β1 Collagen (I, Iv, IX)
αDβ2 ICAM-3 vCAM-1
αLβ2 ICAM-1,2,3,5
αMβ2 iC3b, fibrinogen
αXβ2 iC3b, fibrinogen
αvβ1 Fibronectin, vitronectin
αvβ3 Fibronectin, vitronectin, fibrinogen
αvβ5 vitronectin
αvβ6 Fibronectin, TGF-B-LAP
αvβ8 vitronectin, TGF-B-LAP
αIIBβ3 Fibronectin, fibrinogen
α6β4 Laminin
α4β7 MadCAM-1, fibronectin, VCAM-1
αEβ7 E-cadherin
Notes: Collagen receptors are highlighted yellow, laminin receptors are highlighted 
gray, RGD receptors are highlighted aqua, and leukocyte-specific receptors are 
highlighted pink. with kind permission from Springer Science+Business Media: 
Cell and Tissue Research, Integrins, 339, 2010, 269–280, Barczyk M, Carracedo S, 
Gullberg D, tables 1 and 2.
Abbreviations: ICAM, intercellular adhesion molecule; iC3b, proteolyticly inactive 
product of the complement cleavage fragment C3b; vCAM, vascular cell adheson 
molecule; MadCAM, mucosal addresion cell adhesion molecule; vEGF, vasular endothelial 
growth factor; TGF, transforming growth factor; LAP, latency-associated peptide.
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complex to form the ligand-binding head of the integrin.20,21 
The use of activating and conformation-specific antibodies 
also suggests that the β chain is extended in the active inte-
grin.22 It has since been identified that the hybrid domain in 
the β chain is critical for integrin activation, and a swing-out 
movement of this leg activates integrins.23
The β subunit regulates integrin activation though 
conformational changes at the “knee” of the β subunit 
leg. The knee is located between the plexin-semaphorin-
integrin/I-epidermal growth factor-1 and I-epidermal growth 
factor-2 domains; this bend in the β subunit results in the 
ligand-binding head pointing towards the membrane, which 
is unfavorable for ligand binding.24 During integrin activation 
a “knee-jerk” extension occurs to give the high-affinity/active 
conformation with the ligand-binding head repositioned away 
from the membrane in a more favorable position for ligand 
binding.24,25 The affinity of the receptor is dependent on the 
conformation of the receptor. Low affinity occurs when the 
headpiece is closed and bent, with the N-terminal ligand-
binding pocket close to the membrane. Intermediate affinity 
occurs when the headpiece is closed but extended; high 
affinity occurs when the headpiece is open and extended,19 
resulting in the ligand-binding pocket moving away from 
the membrane. RGD peptides and small ligands can bind 
integrins that are not fully activated, whereas larger ligands 
such as fibrinogen and fibronectin cannot.26,27 Clustering of 
low-affinity receptors enhances both the strength of ligand 
binding and the formation of adhesion complexes.28
Signaling that occurs with binding 
of integrins and ECM
Integrin extracellular binding activity is regulated from inside 
the cell and binding to the ECM induces signals that are 
transmitted into the cell.15 This bidirectional signaling requires 
dynamic, spatially, and temporally regulated formation and 
disassembly of multiprotein complexes that form around the 
short cytoplasmic tails of integrins. Ligand binding to integrin 
family members leads to clustering of integrin molecules in 
the plasma membrane and recruitment of actin filaments and 
intracellular signaling molecules to the cytoplasmic domain of 
the integrins.24 This forms focal adhesion complexes which are 
able to maintain not only adhesion to the ECM but are involved 
in complex signaling pathways which include establishing cell 
polarity, directed cell migration, and maintaining cell growth 
and survival. Initial activation through integrin adhesion to 
matrix recruits up to around 50 diverse signaling molecules 
to assemble the focal adhesion complex which is capable of 
responding to environmental stimuli efficiently.29,30 Mapping 
of the integrin adhesome binding and signaling interactions 
identified a network of 156 components linked together which 
can be modified by 690 interactions.31
The binding of the adaptor protein talin to the β subunit 
cytoplasmic tail is known to have a key role in integrin 
activation.7 This is thought to occur through the disruption of 
inhibitory interactions between α and β subunit cytoplasmic 
tails.32 Talin also binds to actin and to cytoskeletal and signal-
ing proteins.33 This allows talin to directly link activated integ-
rins to signaling events and the cytoskeleton. Other molecules 
which may participate in integrin activation alongside talin 
include members of the kindlin family.34 Inhibition of kindlin 
binding inhibits integrin activation, whereas coexpression of 
kindlin and talin activates integrins. 
After the initial activation resulting from binding of the 
integrin to ECM, the focal adhesions mature into multiprotein 
complexes at the cytoplasmic face of the clustered, ligand-
bound integrins. The binding of a ligand to integrins results 
ECM
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Figure 1 Integrin binding to extracellular matrix (ECM). Conformational changes to integrin structure and clustering of subunits which allow enhanced function of the 
receptor. (A) No binding; (B) after binding to ECM integrin subunits, the knee of the receptor is bent to allow exposure of intracellular binding sites; and (C) clustering of 
subunits allows enhanced activity of receptors.
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in a rise in intracellular calcium ion concentration. This leads 
to the activation of various kinase families including tyrosine 
kinases, such as focal adhesion kinase (FAK) and Fyn, and 
Src family kinases (SFKs).35 FAK is ubiquitously expressed 
and is phosphorylation regulated. FAK interacts with the 
adaptor proteins talin and paxillin, which recruit FAK to focal 
adhesion.36,37 FAK is autophosphorylated during integrin 
clustering and allows the presentation of docking sites for 
Src homology 2 domain-containing proteins.38 These include 
SFKs which become activated on docking and phosphorylate 
FAK, promoting its kinase activity. SFKs are rapidly activated 
following integrin-ligand interactions. SFKs then activate 
downstream kinases and adaptors during these initial events.39 
SFKs can bind directly to β integrin tails which contributes 
to the activation of kinase activity.40 Integrin-linked kinase 
has a major role as a signaling scaffold at integrin adhesions. 
Kinase activities of integrin-linked kinase are uncertain as 
the kinase domain lacks catalytic residues that are normally 
conserved among protein kinases; however in vitro studies 
suggest there may be some catalytic activity, though this has 
not been identified in vivo.41
Paxillin acts as an adaptor protein for α4,42 β1,43 and 
β344 subunits. Association of FAK with integrins in vivo is 
thought to be indirect, and most probably occurs through 
interactions with paxillin.45,46 Paxillin is one of the earliest 
proteins to be detected in nascent adhesions where it is 
rapidly organized.47 Therefore paxillin has an important 
role in the assembly of focal adhesions. Paxillin acts as 
a scaffold48 through the many protein–protein interaction 
modules in its structure such as leucine-rich repeats LIM 
domains and a proline rich region. Paxillin also has multiple 
phosphorylation sites which can be involved in the regulation 
of protein-protein interactions. These sites are targeted by 
diverse kinases including p21-activated kinase, FAK-Src, 
receptor for activated C-kinase 1, and mitogen-activated 
protein kinase.48 Paxillin has been shown to be a direct 
binding partner for the vinculin tail domain,49 however in 
mature adhesions paxillin and vinculin appear to uncouple50 
with only transient interactions. In mature adhesions 
paxillin mediates the binding of kinases, phosphatases, 
actin-binding proteins (eg, vinculin and the parvins), and 
regulators and effectors of the Rho family of small guanosine 
triphosphatases.
Deactivation of integrins through negative regulators 
is important in controlling the appropriate expression of 
integrins and adhesion. Negative regulation can occur at 
any point in the integrin signaling process, if molecules 
which act as negative regulators are activated. The kinase 
properties of mitogen-activated protein kinases and 
extracellular-signal-related kinase 1 and 2 suppress integrin 
activation in many cell types when activated by HRas.51 
In the final stages of integrin activation the association of 
negative regulators with talin or either integrin tail can lead 
to disassociation of integrin and disruption in the adhesion 
complex. Phosphatidylinositol phosphate kinase type Iγ90 
competes with β integrin tails for binding to talin-1, and is 
believed to act as a molecular switch which may regulate 
dynamic focal adhesion turnover.52,53 Phosphorylation 
events which occur during integrin-mediated focal adhesion 
development lead to activation of kinases which can 
tyrosine phosphorylate the β integrin tail and lead to altered 
conformation of the receptor and/or altered affinity for 
interacting molecules. Phosphorylation of tyrosine in the 
membrane proximal asparagine-proline-X-tyrosine motif of 
β integrin tails promotes competition with phosphotyrosine-
binding domain-containing proteins which do not activate 
integrins. Tyrosine phosphorylation in this region may reduce 
the affinity of interactions with talin-1.54 Other mechanisms 
by which the interaction between β integrin tail and talin can 
be disrupted is through competition for binding which occurs 
with filamin A55 or integrin cytoplasmic domain associated 
protein 1.56 Thus binding of integrins to ECM initiates a series 
of signaling cascades resulting from the assembly of the focal 
adhesion complex (interactions summarized in Figure 2). 
These can be complementary or independent from each 
other since many cascades diverge into each other at different 
intervals and lead to alteration of gene expression.
Figure 2 Simplified focal adhesion complex generated after integrin–extracellular 
matrix binding. Proteins shown are important molecules involved in focal adhesion 
development and intracellular signaling resulting from integrin–extracellular matrix 
interactions.
Abbreviations: FAK, focal adhesion kinase; SFK, Src family kinase.
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Genetic programming that occurs 
with the binding of integrins  
to the ECM
Signal transduction pathway activation arising from integrin-
ECM binding results in changes in gene expression of cells 
and leads to alterations in cell and tissue function. Various 
different effects can arise depending on the cell type, matrix 
composition, and integrins activated. One way in which 
integrin expression is important in genetic programming is 
in the fate and differentiation of stem cells.
Osteoblast differentiation occurs through ECM interac-
tions with specific integrins to initiate intracellular signaling 
pathways leading to osteoblast-specific gene expression57 
and disruption of interactions between integrins and col-
lagen; fibronectin blocks osteoblast differentiation and 
mineralization. Disruption of α2 integrin prevents osteoblast 
differentiation, and activation of the transcription factor 
osteoblast-specific factor 2/core-binding factor α1.58 It was 
found that the ECM-integrin interaction induces a modifica-
tion in osteoblast-specific factor 2/core-binding factor α1 to 
increase its activity as a transcriptional enhancer rather than 
increasing protein levels. It was also found that modification 
of α2 integrin alters induction of the osteocalcin promoter; 
inhibition of α2 prevents activation of the osteocalcin pro-
moter,58 while overexpression enhanced osteocalcin promoter 
activity.59 It has been suggested that integrin-type I collagen 
interaction is necessary for the phosphorylation and activa-
tion of osteoblast-specific transcription factors present in 
committed osteoprogenitor cells.60
Generation of cartilage cells from stem cell differentiation 
(chondrogenesis) occurs through coordinated effects of 
growth, differentiation factors, and ECM components. 
In addition to hormone growth factors and transforming 
growth factor-β, many other factors drive the differentiation 
of mesenchymal stem cells towards cartilage, including 
ECM molecules, such as syndecans and glypicans or 
fibulins.61 Thus integrin-mediated signaling appears to play 
an important role in the generation and maintenance of the 
chondrocytic phenotype during chondrogenic differentiation. 
During chondrogenesis there is a defined integrin expression 
pattern.62
The integrin-specific maturation of mesenchymal stem 
cells when plated on ECM ligands is being utilized in 
 tissue repair. Adult mesenchymal stem cells are pluripo-
tent  progenitor/stem cells and can be differentiated into 
 chondrocytes, tendonocytes, adipocytes, and osteoblasts.63 
Coating of engineered bioimplants with ECM, such as 
f ibronectin fragments, can enhance integrin-mediated 
 adhesion in vitro, osteogenic signaling, and differentiation in 
human mesenchymal stem cells which promote bone forma-
tion and functional integration of the implant into bone in 
rat tibiae.64 Similar work with chondrocytes has been more 
difficult as stable cartilage can be formed in vitro, but has 
been less stable in vivo.65
Mechanotransduction: where  
integrins and ECM come together  
in physiology and pathophysiology
The process by which mechanical signals are converted into 
chemical activity and changes in cell behavior is termed 
mechanotransduction. Mechanical loading through move-
ment of joints is essential in the maintenance of connective 
tissues. Movement and mechanical forces maintain healthy 
cartilage,66 bone,67 muscle,68 and tendons69 by regulating 
tissue remodeling. In tissues which are subject to mechani-
cal loading, the relative amounts and organization of matrix 
molecules such as collagen and proteoglycan vary throughout 
the depth of cartilage reflecting the distribution and effect 
of load placed on the tissue. Integrins are one of a number 
of cell surface molecules which are able to sense deforma-
tion of the tissue resulting from mechanical loading, and are 
termed mechanosensitive receptors. Integrins are important 
molecules in mechanotransduction signaling in various tis-
sues within the body,69 and their location between the ECM 
and cell cytoskeleton is ideally suited for their role as a 
mechanoreceptor.
Deformation of the tissue during mechanical loading/
stimulation alters the conformation of the ECM molecules 
and thus their availability to interact with cell surface recep-
tors such as integrins as well as directly activating mechano-
sensitive receptors. Mechanical loading not only stimulates 
cells directly but there is also release of soluble mediators 
from cells such as chondrocytes which can stimulate cell 
surface receptors. During mechanotransduction, integrin 
expression and integrin-matrix affinity is modulated by 
these growth factors and cytokines, and by doing so may 
alter integrin signaling. This may result in altered matrix 
protein production,70stimulation of matrix metalloprotei-
nases and aggrecanases,71,72 or matrix degradation, which 
would affect cell–matrix interactions.73 Similarly, a variety of 
growth factors and cytokines have been shown to be impor-
tant in the regulation of integrin expression and function in 
chondrocytes.3,74,75
Mechanotransduction in chondrocytes occurs through 
several different receptors and ion channels including 
integrins.76 During osteoarthritis the expression of integrins 
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by chondrocytes is altered, resulting in different cellular 
transduction pathways which contribute to tissue pathology. 
In normal adult cartilage, chondrocytes express α1β1, 
α10β1 (collagen receptors), α5β1, and αvβ5 (fibronectin) 
receptors.77,78 During mechanical loading/stimulation of 
chondrocytes there is an influx of ions across the cell 
membrane resulting from activation of mechanosensitive 
ion channels which can be inhibited by subunit-specific 
anti-integrin blocking antibodies or RGD peptides.79 Using 
these strategies it was identified that α5β1 integrin is a 
major mechanoreceptor in articular chondrocyte responses 
to mechanical loading/stimulation.
When a ligand binds to integrin there is a rise in intracel-
lular calcium ion concentration. This leads to the activation 
of tyrosine kinases and intracellular cell signaling pathways. 
In monolayer cultures of chondrocytes, normal cartilage 
mechanical loading/stimulation at 0.33 Hz results in α5β1-
dependent tyrosine phosphorylation of FAK and paxillin 
and activation of protein kinase C.80 This signaling can be 
interrupted by the use of integrin blocking methods. Function 
blocking β1 subunit antibodies inhibit cyclical compression 
induced gene expression of cartilage oligomeric protein in 
both calf articular cartilage explants as well as in alginate/
chondrocyte constructs.81 The use of RGD peptides were 
able to abolish dynamic compression induced cell prolifera-
tion, proteoglycan production, and nitric oxide inhibition in 
bovine three-dimensional agarose/chondrocyte culture.82 
Through a transforming growth factor-β3-dependent path-
way, α5β1 integrins can also mediate signals from dynamic 
compression to enhance proteoglycan synthesis and chon-
drocyte proliferation.83 More recently it has been identified 
that CD47 (integrin-associated protein) is involved in the 
membrane hyperpolarization, tyrosine phosphorylation, and 
elevation of aggrecan messenger ribonucleic acid induced 
by mechanical stimulation, and that this is mediated through 
interactions with α5β1 integrin.84
Although having important roles in maintaining cartilage 
in a healthy state it is widely accepted that mechanical forces, 
either abnormal loads acting upon healthy cartilage or normal 
loading of structurally abnormal cartilage, is involved in the 
pathophysiological processes that lead to osteoarthritis.85 
Injurious loading regimes in normal cartilage include static 
loading (inactivity of weight bearing joints) and high mag-
nitude dynamic loading (high impact sports).
Chondrocytes from diseased cartilage show significant 
differences in cell phenotype, response to catabolic factors, 
and responses to mechanical stimuli. Loss of normal carti-
lage physiology means that the matrix is no longer able to 
protect the chondrocytes from mechanical loading. In an 
attempt to prevent tissue destruction, the chondrocytes try 
to produce new matrix to repair the damage. Osteoarthritis 
is a degenerative disease of cartilage, generally accepted to 
be secondary to the effects of mechanical forces on the joint. 
Articular cartilage is continually remodeled in response to 
both anabolic and catabolic stimuli, but during osteoarthritis 
inflammatory mediators are produced which alter normal 
cell signaling and lead to an increase in the production of 
catabolic molecules.86 Similarly, chondrocytes derived from 
osteoarthritic cartilage show different cellular responses to 
mechanical stimulation in monolayer culture when compared 
to cells from normal joint.
Osteoarthritic chondrocytes show a depolarization 
response to 0.33 Hz stimulation in contrast to the hyper-
polarization response of normal chondrocytes.87 The 
mechanotransduction pathway in chondrocytes derived from 
normal and osteoarthritic cartilage both involve recognition 
of the mechanical stimulus by integrin receptors resulting in 
the activation of integrin signaling pathways leading to the 
generation of a cytokine loop.88 Normal and osteoarthritic 
chondrocytes show differences at multiple stages of the mech-
anotransduction cascade (Figure 3). Early events are similar; 
α5β1 integrin and stretch activated ion channels are activated 
and result in rapid tyrosine phosphorylation events.87 The 
actin cytoskeleton is required for the integrin-dependent 
mechanotransduction leading to changes in membrane poten-
tial in normal but not osteoarthritic chondrocytes.87
The composition of ECM is altered in osteoarthritis 
as a result of altered synthetic activity by chondrocytes 
and the production of proteases, which digest preexisting 
matrix molecules. Osteoarthritic cartilage is characterized by 
a decrease in proteoglycan content, disruption of the collagen 
II fiber network, increase in a variety of glycoproteins (includ-
ing fibronectin, tenascin, and decorin), upregulation of col-
lagen type VI expression, and altered integrin expression. In 
osteoarthritic chondrocytes there is additional expression of 
the integrin subunits α2, occasionally α4, and α3. In both 
normal and osteoarthritic chondrocytes, α1, α5, αV, β1, β4, 
and β5 subunits are present, with upregulated β1 integrin 
expression in chondrocytes from osteoarthritic cartilage.78 
These may result in changes in cell–matrix interactions that 
will influence how a chondrocyte perceives and responds to 
a mechanical load.
Integrin-ECM interactions in mechanotransduction are 
not limited to cartilage and connective tissue. There is evi-
dence in many tissues for a role of integrins as mechanosen-
sors and alterations in their expression and signaling can lead 
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to pathology. In cardiomyocytes, integrins are responsible 
for mechanotransduction. The main integrins expressed are 
α5β1 and αvβ3. Disruption or elimination of either β1 or β3 
impedes pressure-induced hypertrophic signaling and leads 
to heart failure.89 Other cardiovascular pathologies associated 
with altered integrin-mediated mechanics and loss of native 
contractility that can develop over time are hypertension 
and atherosclerosis.90,91 Alteration in integrin sensitivity to 
mechanical loading/stimulation has been shown in cancer.92,93 
These altered integrin responses can facilitate metastasis and 
drive expression of the malignant phenotype.94 Matrix stiff-
ness and cytoskeletal stress are functionally linked through 
key signaling proteins during tumorigenesis which cooperate 
to drive focal adhesion assembly, contributing to a rigid tumor 
microenvironment.95
Conclusion
Cell–matrix interactions are essential for maintaining 
the integrity of tissues. An intact matrix is essential for 
cell survival and proliferation and to allow eff icient 
mechanotransduction and tissue homeostasis. Cell–matrix 
interactions have been extensively studied in many tissues 
and this knowledge is being used to develop strategies to treat 
pathology. This is particularly important in tissues subject 
to abnormal mechanical loading, such as musculoskeletal 
tissues. Integrin-ECM interactions are being used to 
enhance tissue repair mechanisms in these tissues through 
differentiation of progenitor cells for in vitro and in vivo 
use. Knowledge of how signaling cascades are differentially 
regulated in response to physiological and pathological 
external stimuli (including ECM availability and mechanical 
loading/stimulation) will enable future strategies to be 
developed to prevent and treat the progression of pathology 
associated with integrin-ECM interactions.
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